Rucaparib or Physician’s Choice in Metastatic Prostate Cancer
N Engl J Med. 2023 Feb 23;388(8):719-732. doi: 10.1056/NEJMoa2214676.…
Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
Clin Cancer Res. 2023 Jun 13;29(12):2250-2265. doi: 10.1158/1078-0432.CCR-22-3298.ABSTRACTPURPOSE:…
1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model
Front Med (Lausanne). 2023 Jan 9;9:1036322. doi: 10.3389/fmed.2022.1036322.…
Systemic cellular viroimmunotherapy for canine high-grade gliomas
J Immunother Cancer. 2022 Dec;10(12):e005669. doi: 10.1136/jitc-2022-005669.ABSTRACTBACKGROUND:…
Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer
J Immunother Cancer. 2022 Dec;10(12):e005443. doi: 10.1136/jitc-2022-005443.ABSTRACTBACKGROUND:…
Corrigendum to “Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study” [Eur Urol 83 (2023) 15-26]
Eur Urol. 2023 Mar;83(3):e87. doi: 10.1016/j.eururo.2022.11.025.…
Local Resection in Choroidal Melanoma: A Review
J Clin Med. 2022 Dec 1;11(23):7156. doi: 10.3390/jcm11237156.ABSTRACTSurgical…
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer
Adv Sci (Weinh). 2022 Nov 14;10(1):e2204211. doi: 10.1002/advs.202204211.…
Orthotopic murine xenograft model of uveal melanoma with spontaneous liver metastasis
Melanoma Res. 2023 Feb 1;33(1):1-11. doi: 10.1097/CMR.0000000000000860.…
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial
Nat Med. 2022 Nov;28(11):2364-2373. doi: 10.1038/s41591-022-02015-7.…
Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study
Eur Urol. 2023 Jan;83(1):15-26. doi: 10.1016/j.eururo.2022.08.005.…
Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial
Eur J Cancer. 2022 Sep;173:317-326. doi: 10.1016/j.ejca.2022.06.057.…
